Clinical Trial Update: Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating tislelizumab in combination with chemotherapy and radiotherapy as first-line treatment for extensive-stage small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: Extensive-stage Small Cell Lung Cancer (ES-SCLC) | Phase 2 | Status: RECRUITING